Zulaika Abdus-Salaam

At Parexel, I direct SAE and ADR processing, medical monitoring, and pharmacovigilance operations for Phase II and III oncology trials in esophageal and colorectal cancer. I support patient safety through endpoint reviews, lab alert evaluations, protocol waiver assessments, and patient-level safety and efficacy data review.

I lead audit-ready regulatory compliance, including PSURs, DSURs, CAPA implementation, and support for internal and external inspections. I also coordinate DMC and CEC operations, connecting clients, core teams, and external consultants.

Previously at ICON, I supported Phase II and III prostate cancer studies through startup, site activation, enrollment planning, site performance oversight, safety reporting, and cross-functional study delivery. At Fox Chase Cancer Center, I coordinated Phase I–III hematologic oncology research, including protocol amendments, informed consent revisions, IRB submissions, and regulatory documentation.

I'm experienced in clinical trial strategy, oncology development, risk-based escalation, database lock readiness, resource planning, financial oversight, and scientific communication. I bring an MPH in Healthcare Administration and focus on operational execution that protects patients and supports high-quality clinical evidence.